Chair-bound Exergaming in Pre-frail/ Frail Older Adults in Nursing Home

Not Applicable

Recruiting

• Conditions: Frailty in Older Adults

• Registration Number: NCT06849557
• Lead Sponsor: Hong Kong Metropolitan University

Brief Summary

This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents

Detailed Description

Objective To explore the effects of the chair-bound exergaming on the enjoyment of physical activity in in pre-frail/ frail nursing home residents.

To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents.

Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes.

All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control.

1. Intervention group (exergaming group, ERG) Those allocated to the ERG will receive supervised chair-bound exercise programme for 12 weeks.

2. Control group (wait list control, CG) Those allocated to the CG will receive supervised chair-bound exercise programme for 12 weeks after post-assessment.

Study Timeline

• Status Verified: 2025-01
• Study First Submitted: 2025-01-16
• Study First Submitted QC: 2025-02-25
• Study First Posted: 2025-02-27
• Study Start: 2025-04-07
• Last Update Submitted: 2025-05-09
• Last Update Posted: 2025-05-14
• Primary Completion: 2025-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• older adults aged 60 years or older living in the nursing homes;
• pre-frail or frail according to the Fried Frailty Phenotypes;
• ability to understand and execute instructions; and
• ability to sit unassisted on a chair or in a wheelchair.

Exclusion Criteria

• no controlled medical diagnosed of severe cardiometabolic, respiratory and musculoskeletal disorders;
• any conditions that hinder the participation of intervention and assessment; and
• being involved in any other clinical trials.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
enjoyment	T2: immediately (1 week) after intervention	enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
upper extremity endurance	T2: immediately (1 week) after intervention	upper extremity endurance measured by arm curl test

Secondary Outcome Measures

Name	Time	Method
feasibility, acceptability and appropriateness of intervention	T2: immediately (1 week) after intervention	feasibility, acceptability and appropriateness of intervention measured by questionnaire
upper extremity strength	T2: immediately (1 week) after intervention	upper extremity strength measured by handheld dynamometer
cognitive function	T2: immediately (1 week) after intervention	cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
lung capacity	T2: immediately (1 week) after intervention	lung capacity measured by peak flow meter
sitting balance	T2: immediately (1 week) after intervention	sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
mental health	T2: immediately (1 week) after intervention	mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress

Trial Locations

Locations (1)

Hiu Kwong (Tak Yue) Nursing Centre; 🇭🇰 Kowloon, Hong Kong